Imbruvica

jaypirca-for-chronic-lymphocytic-leukemia

Dec 11, 2023

Eli’s Jaypirca: A Beacon of Success in the BTK Inhibitor Market

top-10-oncology-drugs-launches-2023

Feb 24, 2023

Top 10 Expected Oncology Drug Launches in 2023

oncological-drugs-to-be-launch-in-2022

Jan 14, 2022

Most Promising Oncological Drugs Expected to Launch in 2022

Pharma News

Aug 15, 2019

EU approval for Imbruvica; Pharming licenses orphan drug

Recent Pharma News

Jul 02, 2019

FDA’s approval to Pfizer’s Zirabev; Launch of Century Therapeutics; Imbruvica’s recommendation from CHMP

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper